231 related articles for article (PubMed ID: 31077767)
21. Cellular Gene Modulation of HIV-Infected CD4 T Cells in Response to Serial Treatment with the Histone Deacetylase Inhibitor Vorinostat.
Maxwell JW; Falcinelli SD; Nefedov A; Dorfmeier C; Wu G; Dewey M; Webber AL; Archin NM; Margolis DM; Hazuda DJ; Barnard RJO; Howell BJ
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295913
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.
Wei DG; Chiang V; Fyne E; Balakrishnan M; Barnes T; Graupe M; Hesselgesser J; Irrinki A; Murry JP; Stepan G; Stray KM; Tsai A; Yu H; Spindler J; Kearney M; Spina CA; McMahon D; Lalezari J; Sloan D; Mellors J; Geleziunas R; Cihlar T
PLoS Pathog; 2014 Apr; 10(4):e1004071. PubMed ID: 24722454
[TBL] [Abstract][Full Text] [Related]
23. Synergistic reactivation of latent HIV-1 provirus by PKA activator dibutyryl-cAMP in combination with an HDAC inhibitor.
Lim H; Kim KC; Son J; Shin Y; Yoon CH; Kang C; Choi BS
Virus Res; 2017 Jan; 227():1-5. PubMed ID: 27677464
[TBL] [Abstract][Full Text] [Related]
24. HIV latency reversing agents act through Tat post translational modifications.
Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
[TBL] [Abstract][Full Text] [Related]
25. Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages.
Mahboubi B; Gavegnano C; Kim DH; Schinazi RF; Kim B
Retrovirology; 2018 Oct; 15(1):69. PubMed ID: 30316304
[TBL] [Abstract][Full Text] [Related]
26. Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
Marsden MD; Wu X; Navab SM; Loy BA; Schrier AJ; DeChristopher BA; Shimizu AJ; Hardman CT; Ho S; Ramirez CM; Wender PA; Zack JA
Virology; 2018 Jul; 520():83-93. PubMed ID: 29800728
[TBL] [Abstract][Full Text] [Related]
27. BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation.
Cai Y; Abdel-Mohsen M; Tomescu C; Xue F; Wu G; Howell BJ; Ai Y; Sun J; Azzoni L; Le Coz C; Romberg N; Montaner LJ
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355686
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation.
Kuai Q; Lu X; Qiao Z; Wang R; Wang Y; Ye S; He M; Wang Y; Zhang T; Wu H; Ren S; Yu Q
J Med Virol; 2018 Sep; 90(9):1478-1485. PubMed ID: 29704439
[TBL] [Abstract][Full Text] [Related]
29. HIV-2 Depletes CD4 T Cells through Pyroptosis despite Vpx-Dependent Degradation of SAMHD1.
Luo X; Herzig E; Doitsh G; Grimmett ZW; Muñoz-Arias I; Greene WC
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578293
[TBL] [Abstract][Full Text] [Related]
30. Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1.
Martínez-Bonet M; Clemente MI; Serramía MJ; Muñoz E; Moreno S; Muñoz-Fernández MÁ
Sci Rep; 2015 Nov; 5():16445. PubMed ID: 26563568
[TBL] [Abstract][Full Text] [Related]
31. DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV-1 infection of macrophages.
Mlcochova P; Caswell SJ; Taylor IA; Towers GJ; Gupta RK
EMBO J; 2018 Jan; 37(1):50-62. PubMed ID: 29084722
[TBL] [Abstract][Full Text] [Related]
32. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
[TBL] [Abstract][Full Text] [Related]
33. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.
Spina CA; Anderson J; Archin NM; Bosque A; Chan J; Famiglietti M; Greene WC; Kashuba A; Lewin SR; Margolis DM; Mau M; Ruelas D; Saleh S; Shirakawa K; Siliciano RF; Singhania A; Soto PC; Terry VH; Verdin E; Woelk C; Wooden S; Xing S; Planelles V
PLoS Pathog; 2013; 9(12):e1003834. PubMed ID: 24385908
[TBL] [Abstract][Full Text] [Related]
34. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
J Virol; 2018 May; 92(10):. PubMed ID: 29343578
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells.
Kobayashi Y; Gélinas C; Dougherty JP
J Gen Virol; 2017 Apr; 98(4):799-809. PubMed ID: 28113052
[TBL] [Abstract][Full Text] [Related]
36. Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cells.
Shan L; Xing S; Yang HC; Zhang H; Margolick JB; Siliciano RF
J Antimicrob Chemother; 2014 Jan; 69(1):28-33. PubMed ID: 23999005
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.
Laird GM; Bullen CK; Rosenbloom DI; Martin AR; Hill AL; Durand CM; Siliciano JD; Siliciano RF
J Clin Invest; 2015 May; 125(5):1901-12. PubMed ID: 25822022
[TBL] [Abstract][Full Text] [Related]
38. SAMHD1 is active in cycling cells permissive to HIV-1 infection.
Badia R; Pujantell M; Torres-Torronteras J; Menéndez-Arias L; Martí R; Ruzo A; Pauls E; Clotet B; Ballana E; Esté JA; Riveira-Muñoz E
Antiviral Res; 2017 Jun; 142():123-135. PubMed ID: 28359840
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.
Larragoite ET; Nell RA; Martins LJ; Barrows LR; Planelles V; Spivak AM
Biochem Pharmacol; 2022 Jan; 195():114844. PubMed ID: 34801521
[TBL] [Abstract][Full Text] [Related]
40. A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-κB pathway.
Lu W; Yang C; Xu X; Chen C; Hou X; Fang H; Liu S
Life Sci; 2021 Feb; 267():118427. PubMed ID: 32941894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
